Hide Message

Updating the Resource Centre Digital Platform

The Business & Human Rights Resource Centre is at a critical point in its development. Our digital platform is home to a wealth of information on business and human rights, but hasn’t had a visual refresh for a number of years.

We will soon be updating the site to improve its usability and better serve the thousands of people that use our site to support their work.

Please take an advance peek at our new look, and let us know what you think!

Thank you,
Alex Guy, Digital Officer

Find Out More Hide Message

Company survey response

Pfizer

Member of UN Global Compact

Headquarters in USA

Pfizer website

 

🔎 Run a search for “Pfizer”

Get RSS feed of these results

All stories

Article
3 November 2014

Pharmaceutical companies working on Ebola vaccine “driven by humanitarian need” rather than profit, says journalist

Author: Economist (UK)

"Giving it a shot", 1st Nov 2014...

Read more

Article
16 October 2014

Nigeria: Ruling on lawsuit against Pfizer over damages caused by alleged illegal drug testing scheduled for October

Author: Joe Nwankwo, Daily Independent (Nigeria)

"Nigeria: Court Fixes October 27 for Ruling On Pfizer's Trovan Case", 14 Oct 2014...

Read more

Article
8 October 2014

Modi must resist U.S. pressure on drug patents - MSF

Author: Nita Bhalla, Reuters

Prime Minister Narendra Modi must not give in to U.S. pressure to change intellectual property laws which allow India to produce generic medicines poor people can afford, the medical charity Doctors Without Borders (MSF) said…MSF said U.S. officials...

Read more

Article
5 August 2014

Walgreen Co resolves not to transfer headquarters overseas after critics said it would allow company to avoid US tax

Author: Bryce Covert, Think Progress (USA)

"Largest American Drugstore Chain Decides Not To Dodge Taxes By Moving Headquarters Overseas" - 6 August 2014 ...

Read more

Article
1 May 2014

Hearing against US drug corporation starts in Nigeria

Author: Danjuma Abdullahi, Press TV (Iran)

The hearing is underway in the case against Pfizer pharmaceuticals which was refiled by members of the Trovan Victims Forum. The families claim the American pharmaceutical corporation has not compensated them as it agreed to, following an out of court...

Read more

Article
19 February 2014

Allegations of pharmaceutical group's planned opposition to So. Africa reforms to increase access to medicines - company responses/non-responses

Author: Business & Human Rights Resource Centre

In January 2014, the Innovative Pharmaceutical Association of South Africa (IPASA) was accused of planning and funding an advocacy campaign on behalf of its member companies. The campaign allegedly sought to oppose South Africa’s efforts to introduce...

Read more

Company response
19 February 2014

Response by Pfizer: Allegations of pharmaceutical group's planned opposition to So. Africa reforms to increase access to medicines

Read full response

Article
5 February 2014

Nigeria: Pfizer Drug Test Victims File Fresh Suit

Author: Adelanwa Bamgboye & John Chuks Azu, Daily Trust (Nigeria)

One hundred and eighty six victims of the 1996 Pfizer Trovan clinical trial...have filed fresh suit...challenging alleged breach of terms of settlement over the damages suffered in the drugs tests...In the motion...[the claimants] are demanding a total...

Read more

Article
28 January 2014

US shareholders shine light on anti-climate change lobbying

Author: Ross Kendall, Ethical Investor (USA)

American companies including Chevron, Exxon Mobil and Pfizer have been asked to review their lobbying activities related to energy and climate change policy, as part of a new campaign [led] by Walden Asset Management...American Electric Power, ...

Read more

Article
20 December 2013

Study: 51 of 100 Top Companies Emitting Unsustainable Levels of CO2

Author: Mary Mazzoni, TriplePundit

Climate Counts and the Center for Sustainable Organizations just released what they call the “world’s first” science-based company rankings,...[assessing] the emissions performance of 100 companies from 2005 to 2012 within the context of climate...

Read more